Literature DB >> 15333678

Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.

Lauren T May1, Yvonne Lin, Patrick M Sexton, Arthur Christopoulos.   

Abstract

The effects of prolonged exposure of M(2) muscarinic acetylcholine receptors (mAChRs), stably expressed in Chinese hamster ovary cells, to the allosteric modulators gallamine, alcuronium, and heptane-1,7-bis (dimethyl-3'-phthalimidopropyl)-ammonium bromide (C(7)/3'-phth) were compared with the effects of the agonist carbachol (CCh) and antagonists atropine and N-methylscopolamine (NMS). Intact cell saturation binding assays using [(3)H]NMS found that pretreatment of the cells for 24 h with CCh caused a significant down-regulation of receptor number, whereas atropine, NMS, and all three allosteric modulators caused receptor up-regulation. Functional assays using a cytosensor microphysiometer to measure whole-cell metabolic rate found no acute effects of gallamine on receptor signaling, whereas atropine seemed to behave as an inverse agonist. Pretreatment of the cells with gallamine (20 microM) or atropine (20 nM) resulted in a significant enhancement of the maximal effect evoked by CCh. In contrast, CCh (100 microM) pretreatment resulted in a significant reduction in maximal receptor signaling capacity. Time-course experiments revealed that the effects of atropine and gallamine on receptor up-regulation are only visualized after at least 12-h ligand exposure, compared with the more rapid effects of CCh, which achieve steady-state down-regulation within 90 min. Additional experiments monitoring CCh-mediated M(2) mAChR internalization in the presence of gallamine revealed that part of the mechanism underlying the effects of the modulator on receptor expression may involve a change in receptor internalization properties. These findings suggest that, like orthosteric ligands, G protein-coupled receptor allosteric modulators also are able to mediate long-term effects on receptor regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333678     DOI: 10.1124/jpet.104.073767

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.

Authors:  Xia Li; Manoranjan S D'Souza; Ana M Niño; James Doherty; Alan Cross; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2016-02-13       Impact factor: 4.530

Review 2.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

3.  Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.

Authors:  Rachel L Thomas; Christopher J Langmead; Martyn D Wood; R A John Challiss
Journal:  J Pharmacol Exp Ther       Date:  2009-09-18       Impact factor: 4.030

Review 4.  Regulation of G protein-coupled receptors by allosteric ligands.

Authors:  J Robert Lane; Alaa Abdul-Ridha; Meritxell Canals
Journal:  ACS Chem Neurosci       Date:  2013-02-21       Impact factor: 4.418

5.  Allosteric modulation of M1 muscarinic acetylcholine receptor internalization and subcellular trafficking.

Authors:  Holly R Yeatman; J Robert Lane; Kwok Ho Christopher Choy; Nevin A Lambert; Patrick M Sexton; Arthur Christopoulos; Meritxell Canals
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

6.  Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.

Authors:  Katie Leach; Richard E Loiacono; Christian C Felder; David L McKinzie; Adrian Mogg; David B Shaw; Patrick M Sexton; Arthur Christopoulos
Journal:  Neuropsychopharmacology       Date:  2009-11-25       Impact factor: 7.853

7.  Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

8.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

9.  Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells.

Authors:  Mollisa M Elrick; Willis K Samson; John A Corbett; Alison S Salvatori; Lauren M Stein; Grant R Kolar; Aaron Naatz; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-11       Impact factor: 3.619

10.  Metabolic discrimination of select list agents by monitoring cellular responses in a multianalyte microphysiometer.

Authors:  Sven E Eklund; Roy G Thompson; Rachel M Snider; Clare K Carney; David W Wright; John Wikswo; David E Cliffel
Journal:  Sensors (Basel)       Date:  2009-03-23       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.